Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

Pan-Africa Polyvalent Antivenin Supplier

Open
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

AE, 09227-0000, USA

Set-Aside

NONE

Documents

This scope was carved out of SPE2DP-27-Q-0009.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

ANTIVENIN, SNAKE VENOM, PAN-AFRICA

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supplies Pan-Africa polyvalent F(ab)2 immunoglobulin fragments (equine) antivenin for prime contractors delivering DLA supply contracts. Produces biological therapeutics to treat snakebite envenomation from 25 species. Requires pharmaceutical manufacturing facilities and compliance with FDA regulatory approval, MIL-STD-2073-1E, and RP001 DLA Packaging Requirements. Delivers 6 cases (216 vials) of antivenin FOB Destination.

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
Federal
6505--Nitroglycerin Patches
Solicitation # 36E79727R0010
The Department of Veterans Affairs National Acquisition Center is initiating an unrestricted procurement for Nitroglycerin Patches under solicitation 36E79727R0010. This contract will serve the VA, including Consolidated Mail Order Pharmacies and Option 2 State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The award will be granted to a single responsible offeror capable of providing an uninterrupted source of supply for a one-year base period followed by four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs. The procurement covers four strengths of Nitroglycerin patches (0.1 mg, 0.2 mg, 0.4 mg, and 0.6 mg), with estimated annual usage ranging from 2,213 to 10,044 boxes. All patches must be supplied in boxes of 30 and must feature barcoding on both the individual patch and the outside box. Strict labeling requirements apply: the contractor must provide a unique NDC number, and their label must be the only one on the product, without being affixed over another label. Additionally, the labels must allow VA labels to adhere securely over them. This solicitation will be issued in commercial item format per FAR Part 12, with a tentative issuance date of December 1, 2026, and a closing date of December 15, 2026.
Nac Pharmaceuticals (36E797)

POSTED

about 16 hours ago

DEADLINE

in 8 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 325414
New
DIBBS
ANTIVENIN, SNAKE VENOM, PAN-AFRICA
Solicitation # SPE2DP-27-Q-0009
This solicitation, SPE2DP-27-Q-0009, is a small business set-aside request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Pan-Africa polyvalent F(ab)2 immunoglobulin fragments (equine) antivenin. The product is designed to treat snakebite envenomation caused by 25 different species from the Viperidae, Elapidae, Colubridae, and Atractaspididae families. The requirement is for 6 cases, with each case containing 36 vials (6 vials per box, 6 boxes per case). The item is a Type I (Code Q) item with a non-extendable shelf life of 36 months and must be stored at room temperature. The contract is a firm fixed price agreement with delivery required 15 days after order. Shipping is FOB Destination, and the material must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial, utilizing suitable sealed unit containers and exterior shipping containers to prevent damage, with palletization following RP001 DLA Packaging Requirements and MIL-STD-2073-1E. Payment and receiving reports must be processed electronically via the Wide Area WorkFlow (WAWF) system. The procurement incorporates various FAR and DFARS clauses, including requirements for cybersecurity safeguarding, anti-terrorism awareness, and the Buy American and Balance of Payments Program.
Biological Product (except Diagnostic) Manufacturing

POSTED

about 11 hours ago

DEADLINE

in 6 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS